These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34438975)
1. Protective Effect of Baicalin against Pellissery AJ; Vinayamohan PG; Kuttappan DA; Mishra N; Fragomeni BO; Maas K; Mooyottu S; Venkitanarayanan K Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438975 [TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Carvacrol against Gut Dysbiosis and Mooyottu S; Flock G; Upadhyay A; Upadhyaya I; Maas K; Venkitanarayanan K Front Microbiol; 2017; 8():625. PubMed ID: 28484429 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following Wan S; You P; Shi Q; Hu H; Zhang L; Chen L; Wu Z; Lin S; Song X; Luo Y; Wang Y; Ju F; Jin D; Chen Y Front Microbiol; 2024; 15():1368194. PubMed ID: 38638911 [TBL] [Abstract][Full Text] [Related]
5. Wu Z; Xu Q; Gu S; Chen Y; Lv L; Zheng B; Wang Q; Wang K; Wang S; Xia J; Yang L; Bian X; Jiang X; Zheng L; Li L Front Microbiol; 2022; 13():841920. PubMed ID: 35663882 [No Abstract] [Full Text] [Related]
6. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans. Gu W; Li W; Wang W; Kuang D; Zhang W; Lu C; Li N; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J BMC Microbiol; 2020 Aug; 20(1):260. PubMed ID: 32819295 [TBL] [Abstract][Full Text] [Related]
7. Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F Front Microbiol; 2018; 9():2976. PubMed ID: 30619112 [No Abstract] [Full Text] [Related]
9. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463 [TBL] [Abstract][Full Text] [Related]
10. The microbial diversity following antibiotic treatment of Clostridioides difficile infection. Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457 [TBL] [Abstract][Full Text] [Related]
11. The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by Crobach MJT; Ducarmon QR; Terveer EM; Harmanus C; Sanders IMJG; Verduin KM; Kuijper EJ; Zwittink RD Microorganisms; 2020 May; 8(5):. PubMed ID: 32384826 [No Abstract] [Full Text] [Related]
12. Gut Dysbiosis and Vasilescu IM; Chifiriuc MC; Pircalabioru GG; Filip R; Bolocan A; Lazăr V; Diţu LM; Bleotu C Front Microbiol; 2021; 12():651081. PubMed ID: 35126320 [TBL] [Abstract][Full Text] [Related]
13. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins. Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985 [TBL] [Abstract][Full Text] [Related]
14. Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies. De Wolfe TJ; Kates AE; Barko L; Darien BJ; Safdar N Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988143 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143 [TBL] [Abstract][Full Text] [Related]
16. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525 [TBL] [Abstract][Full Text] [Related]
18. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors. Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model. Chilton CH; Crowther GS; Miossec C; de Gunzburg J; Andremont A; Wilcox MH J Antimicrob Chemother; 2020 Jun; 75(6):1458-1465. PubMed ID: 32097465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]